EVH Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.…
Industry Peers
Health Information ServicesKey Statistics
About Evolent Health (NYSE: EVH)
›
Evolent Health (NYSE: EVH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 4,200 employees.
The shares were at 3.430 USD on 19 November 2026, down 17.9% over 52 weeks. Its 52-week range is 2.095 USD to 6.255 USD: the price is 45.2% below the high and 63.7% above the low.
Its market capitalisation is 387.95M USD.
Evolent Health reports return on equity of -128.7%, an operating margin of -1.3% and revenue up 51.3% year over year.
Its debt exceeds its cash by 824.79M USD, a debt-to-equity ratio of 2.38. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 6.000 USD is 74.9% above the current price. The next earnings report is expected on 23 February 2027.